Search results
Gregory Lewis, MD is a cardiologist and section head of heart failure at Massachusetts General Hospital. He also directs the cardiopulmonary exercise testing laboratory and the heart transplant program, and conducts research on exercise physiology and metabolism in heart failure.
- (866) 644-8910
Gregory Lewis is an economist who studies industrial organization, auction theory and market design. He teaches and researches at Harvard University, where he received his PhD from the University of Michigan.
Nov 9, 2023 · Press. Influencers. Gregory Lewis, an accomplished mainstay across New York City jazz and blues scenes, is best known for his domination of the Hammond organ and his mastery of the music of the great pianist-composer Thelonious Monk. Growing up as a 70's kid in Long Island City, part of Lewis' societal foundation is deeply rooted in the height ...
- Jack Bowers
Gregory Lewis is an associate professor of economics at Harvard University and a faculty research fellow at the National Bureau of Economic Research. He studies market design, auction theory, procurement, and online behavior, and has published in top journals such as American Economic Review and Quarterly Journal of Economics.
- Rob’s Intro
- The Interview Begins
- What Is Covid-19?
- If You End Up Infected, How Severe Is It Likely to be?
- How Does Covid-19 Compare to Other Diseases?
- Common Confusions Around Covid-19
- What Types of Interventions Were Available to Policymakers?
- Nonpharmaceutical Interventions
- What Can You Do personally?
- Reflections on The First Few Months of The Pandemic
Robert Wiblin:Hi listeners, this is the 80,000 Hours Podcast, where each week we have an unusually in-depth conversation about one of the world’s most pressing problems and how you can use your career to solve it. I’m Rob Wiblin, Director of Research at 80,000 Hours. Today, we’re taking a step back towards non-COVID-19 content — with an episode tha...
Howie Lempel:Today, I’m speaking with Greg Lewis. Greg researches potential catastrophic risks from advancing biotechnology as Acting Head of the Biosecurity Research Group at Oxford’s Future of Humanity Institute. While there, he’s also a DPhil student. He has a medical degree and a master’s in public health from Cambridge, and has worked as a jun...
Howie Lempel:Cool. And yes, we’re going to ask Greg to give that kind of overview. For listeners who’ve already had that, totally encourage you to skip ahead. But yeah, so just to give a sense of what is this disease? Where did it come from? How scared should we be of it? I was wondering if you could just catch us up. So maybe to start with, you kn...
Howie Lempel:So we’ve talked a little bit about how the disease is spread. If you do end up infected with the disease, how severe is it likely to be? Greg Lewis:Sure. So assessing severity is quite complicated. One of the key challenges is that for many people COVID-19 seems to give either no illness whatsoever, so no symptoms or very few symptoms,...
Howie Lempel:So you’ve done a good job characterizing the basic situation and sort of lining up what this virus looks like, and I think it’d be helpful to contextualize it a bit. So you can think of, like on the one hand, you hear comparisons between COVID and the seasonal flu often from people who are least concerned. And then on the other hand, y...
Howie Lempel:Great. So I guess maybe moving on, there are, I guess, specific questions about characteristics of the virus and the disease that seem to come up over and over again, where I haven’t been able to get an answer that I feel like I really understand. So shooting it by a former doctor and seeing how that goes just seemed like a good opport...
Howie Lempel:So I guess once the outbreak started, if you could just talk through what types of interventions were available to policymakers and public health officials? Greg Lewis:Sure. Maybe I could subdivide into what you might do for an individual patient versus what you might do for an at risk population. So, as unfortunately was noted also qu...
Howie Lempel:So changing topics a bit from the pharmaceuticals. I think what I sort of got from the last section is we’re probably going to be waiting 12 to 18 months until a vaccine. Hopefully, in the meantime, we’ll be getting some help from antivirals, from preparing hospitals and training and better equipment. And then, there’s just sort of thi...
Howie Lempel:So moving onto another topic that comes up is we often have followers, readers, listeners who want to know, I guess, whether they ought to be helping out with the epidemic and what they can be doing. So I guess I’m curious about your take on stuff everybody should be doing to help, and then maybe stuff that certain groups of people can...
Howie Lempel:On that note, maybe it makes sense to take a step back and reflect on the first few months of the pandemic more broadly. So one thing that I think really stood out was just the amount of real time information that was coming out and the speed of research and speed of information which I think has been really cool. It’s been really dist...
Greg Lewis is an economist who studies industrial organization, auction theory and market design. He has a PhD from the University of Michigan and works on topics such as online advertising, electricity markets and highway procurement.
Gregory Lewis, M.D. Professor of Medicine. Harvard Medical School. Physician Investigator (Cl) Cardiovascular Research Center, Mass General Research Institute. Associate Physician. Medicine-Cardiology, Massachusetts General Hospital. Education. MD University of Rochester, School of Medicine and Dentistry 1999.
